The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
The U.S. FDA approved Bydureon and Bydureon BCise (exenatide extended-release) injection to be used in addition to diet and exercise to improve ...
read more
MediPharm Labs Corp., a pharmaceutical company specialized in research-driven development and manufacturing of cannabis API and finished products, has...
read more
Spanish biopharmaceutical company Biofabri and IAVI, an international nonprofit research organization focused on developing vaccines and antibodies ...
read more
Curia, formerly AMRI, agreed to acquire LakePharma Inc., a privately held biologics drug discovery, clinical research, development and manufacturing ...
read more
NRx Pharmaceuticals, Inc. and Quantum Leap Healthcare Collaborative™ have begun treating patients with inhaled ZYESAMIÔ (Aviptadil), in the I-SPY ...
read more
Curia, formerly AMRI, a leading contract research, development and manufacturing organization, agreement to acquire Integrity Bio Inc, a privately ...
read more
Merck has announced a second collaboration agreement in its Bioelectronics innovation field with Innervia Bioelectronics. The aim of the collaboration...
read more
SRI International (SRI) announced a drug discovery research collaboration with Sanofi. By leveraging SRI’s SynFini™ platform, an artificial ...
read more
PharmStars, a digital-health accelerator that launched earlier this month, announces its founding pharma members: Boehringer Ingelheim, Eli Lilly and ...
read more
The FDA approved Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) as a component of a chemotherapy regimen to treat acute lymphoblastic ...
read more
The U.S. FDA approved a nasal antihistamine for nonprescription use through a process called a partial prescription to nonprescription switch. The FDA...
read more
Hope Biosciences Stem Cell Research Foundation (HBSCRF) has received FDA authorization for a Phase II clinical trial to assess the efficacy and safety...
read more
The U.S. FDA approved Pradaxa (dabigatran etexilate) oral pellets to treat children 3 months to less than 12 years old with venous thromboembolism (a ...
read more
Blackstone Life Sciences has committed $250 million towards the launch of a new autologous and allogeneic universal chimeric antigen receptor (CAR) T-...
read more
MannKind Corporation and United Therapeutics Corporation announced that the U.S. Food and Drug Administration (FDA) accepted for priority review of ...
read more